The Purification Insights Blog

Affordable and safe biosimilars for affordable healthcare

Posted by The Bio-Works Team on Oct 2, 2019 3:19:08 PM

When it comes to many serious and challenging diseases, healthcare has reached a point of unsustainability, due to drug costs. For example, sustained therapy for an autoimmune disease or cancer, involving large amounts of monoclonal antibodies (mAbs), might not be a viable option for simple economic reasons. As a consequence, healthcare authorities want to reduce the cost of drugs by encouraging the development of biosimilars. When biological drugs are off-patent they can be copied – which is cheaper than developing the novel drug, but still challenging because of the need to demonstrate the same efficacy and safety. Drug purification, a key to successful manufacture of biologicals, must also adapt by exploiting products and technologies that lower the overall cost of production.

Read More

Topics: mAbs, Biologics, Biopharmaceuticals, Biosimilars

Website

GET SOME PURIFICATION WISDOM

...and simplify your life

Managing purification protocols is never easy. So, Bio-Works’ experts have got together to provide our best inspiration and tips - whether you’re just starting up or already on the way to the next, satisfying success.

We’ll share all our best knowledge and hard-earned insights.
Here you’ll find:

  • Comprehensive overviews
  • Short focus articles on method details
  • Tips and tricks to smooth out wrinkles

It’s simple, just subscribe here and start collecting purification wisdom, for free!

Subscribe Here!

Recent Posts